Introduction: the diagnosis of Lassa fever is crucial to confirm cases, as well as to control/prevent nosocomial and community-based transmission and initiation of treatment, which is still limited in the country. Thus, we aimed at providing some information on the laboratory detection of Lassa from suspected cases in Nigeria. Methods: this was a retrospective study of seasonal Lassa fever outbreaks data from 1,263 samples analyzed using Reverse Transcription-Polymerase Chain Reaction (RT-PCR) at the Virology Research Laboratory, College of Medicine, University of Lagos/Lagos University Teaching Hospital between year 2011 and 2017. Data were analyzed using the 21 st edition of SPSS statistical software (2015). Results: the RT-PCR test confirmed the presence of Lassa in 112 (8.9%) comprising 61 (54.4%) males, 48 (42.9%) females and 3 (2.7%) individuals without gender information. Those aged between 18 and 49 years were mostly affected. There was a decline in the detection of Lassa from 4.7% in 2011/2012 to less than 1% by the 2014/2015. However, during the 2015/2016 and 2016/2017 seasons the detection rates increased to 10.4% and 15.1% respectively. The Northern region of Nigeria reported high confirmed cases of Lassa. The South Western region also witnessed an increased Lassa fever positivity rate of 13.4% of which Lagos and Ogun states being the focal state of Lassa activity in the region. Conclusion: these established the need for heightening the continued surveillance for Lassa as well as the establishment of other testing facilities within these endemic regions for prompt diagnosis of Lassa fever.
Introduction
Lassa virus (LASV), a member of the family; Arenaviridae is the causative agent of Lassa fever (LF), or Lassa hemorrhagic fever which is characterized by a common acute and often fatal febrile syndrome endemic to West Africa [1] [2] [3] [4] . Lassa fever, an infectious illness is estimated to affect 150,000 to 300,000 people in West Africa causing up to 5,000 deaths per year and is associated with significant morbidity and mortality [3] [4] [5] . However, sero-epidemiologic survey had suggested that the number of cases might be much higher, reaching 3 million cases and 67,000 fatalities per year [6] . Overall, the population at risk might include as many as 200 million persons living in a large strip of West Africa from Senegal to Nigeria and beyond [7] . Lassa fever differs from most viral haemorrhagic fevers (VHFs) in that it is endemic to a large geographic area of sub-Saharan Africa. Human cases of LF have been reported in (or imported from) Guinea, Sierra Leone, Liberia, Mali, Burkina Faso, and Nigeria; however, LF outbreaks seem to be restricted to Guinea, Sierra Leone, Liberia (the Mano River Union region), and Nigeria [2, [7] [8] [9] . The Multimammate rat Mastomys natalensis, discovered in 1974 as a natural host and reservoir of lassa virus (LASV) is a commensal rodent ubiquitous in Africa [2, 3, [10] [11] [12] . However, other reservoirs such as Hylomyscus pamfi and Mastomys erythroleucus had also been discovered to harbor Lassa [3] . Although the routes of LASV infection are poorly characterized and the actual burden of the disease still not fully determined, humans probably get infected by eating contaminated food [13] , by inhaling virus-contaminated aerosols [14] , or while butchering infected rat meat [15] . Person-toperson transmission of LASV is well documented, mostly in the form of nosocomial outbreaks [13] . Presently, there is no licensed vaccine or immunotherapy available for prevention or treatment of this disease. International transportation to and from Africa had increased dramatically in the last decade, further increasing the risk for infectious disease exportation from endemic areas [16, 17] . Unlike the rare outbreaks of Ebola Virus Disease (EVD), LF cases in sub-Saharan Africa are common and occur annually, therefore posing a continuous theoretical threat to other parts of Africa and the world at large.
In West Africa, since Lassa fever presents with signs and symptoms related to numerous other febrile endemic diseases such as malaria, dengue, influenza and yellow fever, differentiating between the agents of these illnesses remains a major challenge [18] . More often than not, non-specific treatment for malaria or bacterial infection are instituted, while Lassa fever is only suspected when a patient fails to improve with antimalarial and antibiotic therapy. Therefore, laboratory testing is needed to confirm the diagnosis [19] . Reliable laboratory diagnosis is crucial for the control and prevention of nosocomial and community-based transmission, as well as the initiation of ribavirin treatment. Various techniques are available for the diagnosis of Lassa fever, which includes viral culture, antigen and antibody detection assays and nucleic acid detection methods.
Although, viral culture is the "gold standard" for diagnosis, its use is limited by the non-availability of a Biosafety level 4 (BSL-4) facility, the amount of monetary investment and time involved for such testing to be performed [18] . Antigen and antibody detection assays may provide a rapid diagnosis, but there is a high degree of false positive results once the antigenemia period has resolved in most patients [18] . Thus, nucleic acid-based assays such as the Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) remains the available diagnostic method, which could be carried out using specimens that has been inactivated in a glove box and analyzed under Biosafety Level 2 (BSL-2) facilities [17, 18] . In Nigeria, the Figure   4 ). However, the South Western region also witnessed an increased Lassa fever positivity rate of 13.4% of which Lagos and Ogun being the focal states of Lassa activity in the region (Figure 3, Figure 4 ).
Discussion
Despite growing interest in Lassa fever, our knowledge of its actual incidence, burden, ecology, epidemiology and distribution of Lassa virus in West Africa is limited. The data in this study shows that Lassa fever cases are being detected in more states in Nigeria, which suggests that the infection is much more common than previously recognized as documented in this study [2] . Our study shows that the increase in LASV detection in one of the three LSV diagnostic centres in the country during this period indicates the changing geographic distribution of Lassa fever in Nigeria. The geographic location of the reservoirs and human cases within the country remains a major issue in determining the actual incidence and burden of LF as humans can move large distances after exposure before disease is detected. Other confounding factors that may affect the geographic distribution which also complicate diagnosis includes; the fairly elongated incubation period and non-specific clinical presentation very similar to other common and endemic African diseases; possible importation of LF Page number not for citation purposes 4 from the states, countries and regions endemic for LF to other places not originally known for Lassa activity and the demonstrated evidence that there are other rodent reservoirs of LASV within the West African sub-region requires further evaluations [3, 4, [23] [24] [25] [26] [27] [28] . The increasing detection patterns of LF as documented in this study was similar to the notable increase in suspected and confirmed LF outbreaks across a growing area in the West African sub-region. Regional urbanization and growing transport connectivity [28, 29] . The region has also been forecasted to experience strong climate change effects, impacting crop yields alongside other important ecosystem services [30] . Such anthropogenic processes are thought to be major drivers of zoonotic and vector-borne diseases [31] . 
